Prospective-retrospective biomarker analysis for regulatory consideration: white paper from the industry pharmacogenomics working group.
Patterson SD, Cohen N, Karnoub M, Truter SL, Emison E, Khambata-Ford S, Spear B, Ibia E, Sproule R, Barnes D, Bhathena A, Bristow MR, Russell C, Wang D, Warner A, Westelinck A, Brian W, Snapir A, Franc MA, Wong P, Shaw PM.
Patterson SD, et al. Among authors: khambata ford s.
Pharmacogenomics. 2011 Jul;12(7):939-51. doi: 10.2217/pgs.11.52.
Pharmacogenomics. 2011.
PMID: 21787188